Home > Cashflow Statement > DIVIS LABORATORIES

DIVIS LABORATORIES
Cash Flow from Financing Activities

    Back to Cashflow Statement
DIVIS LABORATORIES is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
COMMUNITY POLL
for DIVIS LABORATORIES
Please provide your vote to see the results

DIVIS LABORATORIES Last 5 Year Cash Flow from Financing Activities History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Cash Flow from Financing Activities ₹-799 Cr₹-797 Cr₹-532 Cr₹-35 Cr₹-1,091 Cr

What is the latest Cash Flow from Financing Activities ratio of DIVIS LABORATORIES ?

The latest Cash Flow from Financing Activities ratio of DIVIS LABORATORIES is ₹-799 Cr based on Mar2024 Consolidated results.
Year Cash Flow from Financing Activities
Mar2024₹-799 Cr
Mar2023₹-797 Cr
Mar2022₹-532 Cr
Mar2021₹-35 Cr
Mar2020₹-1,091 Cr

How is Cash Flow from Financing Activities of DIVIS LABORATORIES Trending?

Years Cash Flow from Financing Activities % Change
Mar2024 ₹-799 Cr
Negative
Mar2023 ₹-797 Cr
Negative
Mar2022 ₹-532 Cr
Negative
Mar2021 ₹-35 Cr
Negative
Mar2020 ₹-1,091 Cr -

Compare Cash Flow from Financing Activities of peers of DIVIS LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
DIVIS LABORATORIES ₹152,628.0 Cr -2.9% -0.3% 63.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹394,223.0 Cr -4.1% -9.8% 8.2% Stock Analytics
CIPLA ₹119,067.0 Cr 0.1% 4.4% 2.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹102,744.0 Cr -1.3% -6.5% 19% Stock Analytics
DR REDDYS LABORATORIES ₹96,123.8 Cr -4% -5.9% -7.8% Stock Analytics
MANKIND PHARMA ₹95,998.8 Cr -0.8% -7.2% 7.2% Stock Analytics


DIVIS LABORATORIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
DIVIS LABORATORIES

-2.9%

-0.3%

63.8%

SENSEX

-0.8%

-1.6%

3.1%


You may also like the below Video Courses